Cu(II) enhances the effect of Alzheimer's amyloid-β peptide on microglial activation

被引:28
|
作者
Yu, Fengxiang [1 ]
Gong, Ping [1 ]
Hu, Zhuqin [2 ]
Qiu, Yu [1 ]
Cui, Yongyao [1 ]
Gao, Xiaoling [1 ]
Chen, Hongzhuan [1 ]
Li, Juan [1 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Dept Pharmacol, Shanghai 200025, Peoples R China
[2] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Immunol, Shanghai 200025, Peoples R China
基金
对外科技合作项目(国际科技项目); 中国国家自然科学基金;
关键词
Cu(II)-A beta complex; Aggregation; Microglia; Reactive oxygen species; Tumor necrosis factor-alpha; Nitric oxide; NF-kappa B; NITRIC-OXIDE SYNTHASE; INFLAMMATORY RESPONSE; HYDROGEN-PEROXIDE; N-ACETYLCYSTEINE; MOUSE MODEL; DISEASE; EXPRESSION; LIPOPOLYSACCHARIDE; PROLIFERATION; NEUROTOXICITY;
D O I
10.1186/s12974-015-0343-3
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Aggregated forms of amyloid-beta (A beta) peptides are important triggers for microglial activation, which is an important pathological component in the brains of Alzheimer's patients. Cu(II) ions are reported to be coordinated to monomeric A beta, drive A beta aggregation, and potentiate A beta neurotoxicity. Here we investigated whether Cu(II) binding modulates the effect of A beta on microglial activation and the subsequent neurotoxicity. Methods: A beta peptides were incubated with Cu(II) at an equimolar ratio to obtain the Cu(II)-A beta complex. Primary and BV-2 microglial cells were treated with Cu(II)-A beta, A beta, or Cu(II). The tumor necrosis factor-alpha (TNF-alpha) and nitric oxide levels in the media were determined. Extracellular hydrogen peroxide was quantified by a fluorometric assay with Amplex Red. Mitochondrial superoxide was detected by MitoSOX oxidation. Results: Incubation of Cu(II) with A beta confers different chemical properties on the resulting complex. At the subneurotoxic concentrations, Cu(II)-A beta (but not A beta or Cu(II) alone) treatment induced an activating morphological phenotype of microglia and induced the microglial release of TNF-alpha and nitric oxide as well as microglia-mediated neuronal damage. Cu(II)-A beta-triggered microglial activation was blocked by nuclear factor (NF)-kappa B inhibitors and was accompanied with NF-kappa B activation. Moreover, Cu(II)-A beta induced hydrogen peroxide release, which was not affected by NADPH oxidase inhibitors. Mitochondrial superoxide production was increased after Cu(II)-A beta stimulation. N-acetyl-cysteine, a scavenger of reactive oxygen species (ROS), inhibited Cu(II)-A beta-elicited microglial release of TNF-alpha and nitric oxide as well as the microglia-mediated neurotoxic effect. Conclusion: Our observations suggest that Cu(II) enhances the effect of A beta on microglial activation and the subsequent neurotoxicity. The Cu(II)-A beta-triggered microglial activation involves NF-kappa B activation and mitochondrial ROS production.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Cu(II) enhances the effect of Alzheimer’s amyloid-β peptide on microglial activation
    Fengxiang Yu
    Ping Gong
    Zhuqin Hu
    Yu Qiu
    Yongyao Cui
    Xiaoling Gao
    Hongzhuan Chen
    Juan Li
    Journal of Neuroinflammation, 12
  • [2] Iron(II) Binding to Amyloid-β, the Alzheimer's Peptide
    Bousejra-ElGarah, Fatima
    Bijani, Christian
    Coppel, Yannick
    Faller, Peter
    Hureau, Christelle
    INORGANIC CHEMISTRY, 2011, 50 (18) : 9024 - 9030
  • [3] Mechanisms of microglial activation by Alzheimer amyloid peptide
    Fassbender, K
    Walter, S
    Kühl, S
    Liu, Y
    Muehlhauser, F
    Landmann, R
    Ulmer, TK
    Beyreuther, K
    GLIA, 2003, : 16 - 16
  • [4] Role of aspartate-1 in Cu(II) binding to the amyloid-β peptide of Alzheimer's disease
    Karr, Jesse W.
    Szalai, Veronika A.
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2007, 129 (13) : 3796 - +
  • [5] Cu(II) binding to monomeric, oligomeric, and fibrillar forms of the Alzheimer's disease amyloid-β peptide
    Karr, Jesse W.
    Szalai, Veronika A.
    BIOCHEMISTRY, 2008, 47 (17) : 5006 - 5016
  • [6] Role of aspartate-1 in Cu(II) binding to the amyloid-β peptide of Alzheimer's disease
    Karr, Jesse W.
    Szalai, Veronika A.
    1600, American Chemical Society, Columbus, United States (129):
  • [7] Alzheimer's Disease and the Amyloid-β Peptide
    Murphy, M. Paul
    LeVine, Harry, III
    JOURNAL OF ALZHEIMERS DISEASE, 2010, 19 (01) : 311 - 323
  • [8] Effect of heparin on biological activity of Alzheimer's amyloid-β peptide
    Donarini, C
    Rossi, E
    De Luigi, A
    De Simoni, MG
    Agostoni, A
    Bergamaschini, L
    MOLECULAR IMMUNOLOGY, 2001, 38 (2-3) : 85 - 85
  • [9] Mixed Ligand Cu(II) Complexes of a Model Therapeutic with Alzheimer's Amyloid-β Peptide and Monoamine Neurotransmitters
    Drew, S.
    Kenche, V.
    Masters, C.
    Barnham, K.
    Zawisza, I.
    Bal, W.
    Barnham, K.
    Drew, S.
    JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY, 2014, 19 : S672 - S672
  • [10] Metabolism of amyloid-β peptide and Alzheimer's disease
    Iwata, N
    Saido, TC
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2006, 100 : 51P - 51P